KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Esperion Therapeutics (ESPR) Other Operating Expenses (2020 - 2026)

Esperion Therapeutics filings provide 6 years of Other Operating Expenses readings, the most recent being -$185.8 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 824.84% to -$185.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$84.4 million, a 223.05% decrease, with the full-year FY2025 number at -$84.4 million, down 223.05% from a year prior.
  • Other Operating Expenses hit -$185.8 million in Q4 2025 for Esperion Therapeutics, down from $41.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $41.3 million in Q3 2025 to a low of -$185.8 million in Q4 2025.
  • Median Other Operating Expenses over the past 5 years was $9.6 million (2022), compared with a mean of $3.4 million.
  • Biggest five-year swings in Other Operating Expenses: surged 5654.84% in 2021 and later crashed 824.84% in 2025.
  • Esperion Therapeutics' Other Operating Expenses stood at $5.1 million in 2021, then decreased by 18.03% to $4.2 million in 2022, then skyrocketed by 175.29% to $11.5 million in 2023, then soared by 123.81% to $25.6 million in 2024, then crashed by 824.84% to -$185.8 million in 2025.
  • The last three reported values for Other Operating Expenses were -$185.8 million (Q4 2025), $41.3 million (Q3 2025), and $28.5 million (Q2 2025) per Business Quant data.